Panacea Biotec, India's 3rd largest biotechnology company has introduced indigenously developed high quality Oncology product -- CABAPAN (Cabazitaxel Injection), for treatment of metastatic Castration Resistant Prostrate Cancer (mCRPC).
Prostate is the second leading site of cancer amongst males with rising mortality rate in India. With ever changing lifestyles, increased awareness, better diagnostic techniques and increased accessibility to medical treatment, more cases of Ca Prostate are being diagnosed.
CABAPAN has been developed by the company's state of the art Global Research and Development Center (GRAND), Mumbai and manufactured at modern production facility complying with global current Good Manufacturing Practices (cGMP), at Baddi, Himachal Pradesh.
Panacea Biotec is the third largest biotechnology company as well as among the top 50 pharmaceutical companies of India. The company has product portfolio that’s caters therapeutics areas like pain management, diabetes and cardiovascular management, renal disease management, osteoporosis management, anti-tubercular, gastro-intestinal.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: